Symbol="FHTX"
AssetType="Common Stock"
Name="Foghorn TherapeuticsÂ Inc"
Description="Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops drugs that target genetically determined dependencies within the chromatin regulatory system. The company is headquartered in Cambridge, Massachusetts."
CIK="1822462"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="500 TECHNOLOGY SQUARE, SUITE 700, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="320378000"
EBITDA="-122086000"
PERatio="None"
PEGRatio="None"
BookValue="-1.179"
DividendPerShare="0"
DividendYield="0"
EPS="-2.74"
RevenuePerShareTTM="0.52"
ProfitMargin="0"
OperatingMarginTTM="-5.78"
ReturnOnAssetsTTM="-0.197"
ReturnOnEquityTTM="-4.704"
RevenueTTM="21726000"
GrossProfitTTM="-86390000"
DilutedEPSTTM="-2.74"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.247"
AnalystTargetPrice="15.17"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="17.03"
PriceToBookRatio="10.71"
EVToRevenue="2.963"
EVToEBITDA="0.568"
Beta="2.215"
num_52WeekHigh="12.02"
num_52WeekLow="4.51"
num_50DayMovingAverage="8.42"
num_200DayMovingAverage="7.16"
SharesOutstanding="41824800"
DividendDate="None"
ExDividendDate="None"
symbol="FHTX"
open="7.84"
high="7.84"
low="7.51"
price="7.51"
volume="49280.00"
latest_trading_day="2023-08-21"
previous_close="7.90"
change="-0.39"
change_percent="-4.9367%"
aroon_positive_momentum_days="71"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="71"
Volume_recent_avg="82892"
Change_recent_avg="0.02"
Delta_recent_avg="0.59"
Variance_recent_avg="0.3"
Change_ratio_recent_avg="0.16"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="71"
Aroon_momentum_negative="29"
image_negative_thumbnail_id_1="149"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0027.jpeg"
image_negative_thumbnail_id_2="145"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0031.jpeg"
image_neutral_thumbnail_id_1="528"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0071.jpeg"
image_neutral_thumbnail_id_2="545"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0054.jpeg"
image_positive_thumbnail_id_1="968"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0130.jpeg"
image_positive_thumbnail_id_2="664"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0044.jpeg"
image_professor_thumbnail_id_1="1204"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
image_professor_thumbnail_id_2="1185"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
